Chiellini; Grazia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chiellini; Grazia.The latest application filed is for "novel thyromimetics with a biphenylmethane scaffold and their use".

Company Profile

0.15.13

Chiellini; Grazia - Rosignano Solvay IT
Chiellini; Grazia - Madison WI US
Chiellini; Grazia - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Thyromimetics With A Biphenylmethane Scaffold And Their Use App 20220227698 - Puricelli; Guido ; et al.	2022-07-21
N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses Grant 8,987,235 - DeLuca , et al. March 24, 2	2015-03-24
2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs Grant 8,609,643 - DeLuca , et al. December 17, 2	2013-12-17
2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs Grant 8,399,439 - DeLuca , et al. March 19, 2	2013-03-19
2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses App 20120283228 - DeLuca; Hector F. ; et al.	2012-11-08
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs Grant 8,193,170 - DeLuca , et al. June 5, 2	2012-06-05
2-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogs Grant 8,114,859 - DeLuca , et al. February 14, 2	2012-02-14
2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs Grant 7,947,666 - DeLuca , et al. May 24, 2	2011-05-24
Vitamin D analog--RAK, methods and uses thereof Grant 7,803,789 - Deluca , et al. September 28, 2	2010-09-28
2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs Grant 7,741,314 - DeLuca , et al. June 22, 2	2010-06-22
2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs App 20100009947 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs App 20100009946 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs App 20090170820 - DeLuca; Hector F. ; et al.	2009-07-02
2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs App 20090170821 - DeLuca; Hector F. ; et al.	2009-07-02
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone Grant 7,541,349 - DeLuca , et al. June 2, 2	2009-06-02
Vitamin D analog--NEL, methods and uses thereof Grant 7,528,122 - DeLuca , et al. May 5, 2	2009-05-05
2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs App 20080081799 - DeLuca; Hector F. ; et al.	2008-04-03
2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs App 20080081800 - DeLuca; Hector F. ; et al.	2008-04-03
2-methylene-19-nor-(23s)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone And 2-methylene-19-nor-(23r)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone App 20070259953 - DeLuca; Hector F. ; et al.	2007-11-08
Vitamin D Analog - Rak, Methods And Uses Thereof App 20070191317 - DELUCA; Hector F. ; et al.	2007-08-16
Vitamin D Analog - Nel, Methods And Uses Thereof App 20070191316 - DELUCA; Hector F. ; et al.	2007-08-16
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone Grant 7,235,680 - DeLuca , et al. June 26, 2	2007-06-26
2-Methylene-19-nor-(23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone App 20060223782 - DeLuca; Hector F. ; et al.	2006-10-05
Method for creating nuclear receptor activity modulating pharmaceuticals App 20040253648 - Fletterick, Robert J. ; et al.	2004-12-16
Selective thyroid hormone analogs Grant 5,883,294 - Scanlan , et al. March 16, 1	1999-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.